SCHEMBL4700751

SCHEMBL4700751

CCOC(=O)c1c(I)c2cc(-c3ccc(C(F)(F)F)cn3)ccc2n1-c1ccc(OC2CCCC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCK P35557 1/20 0.41
KDM4E B2RXH2 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PPARA Q07869 2/20 0.37
PPARG P37231 1/20 0.37
PPARD Q03181 1/20 0.36
MCHR1 Q99705 1/20 0.36
DGAT1 O75907 3/20 0.35
KCNH2 Q12809 2/20 0.35
ADORA2A P29274 1/20 0.35
FAAH O00519 1/20 0.35
LIPE Q05469 1/20 0.35
THRB P10828 1/20 0.35
ALOX5AP P20292 1/20 0.35
SCN9A Q15858 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
HPGD P15428 1/20 0.34
MAPT P10636 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3569793 0.92 GCK (0.40) GCKKDM4EL3MBTL1PPARAPPARG
SCHEMBL333883 0.90 FAAH (0.38) KDM4EPPARAPPARGPPARDFAAH
SCHEMBL3001004 0.87 KDM4E (0.39) GCKKDM4EL3MBTL1PPARAPPARG
SCHEMBL4697797 0.87 GCK (0.41) GCKKDM4EL3MBTL1PPARAPPARG
SCHEMBL4704618 0.84 GCK (0.37) GCKKDM4EL3MBTL1PPARAPPARG
SCHEMBL3572679 0.83 DGAT1 (0.42) GCKKDM4EL3MBTL1MCHR1DGAT1
SCHEMBL3576199 0.82 PPARG (0.40) PPARAPPARGPPARDMCHR1DGAT1
SCHEMBL3577884 0.82 GCK (0.41) GCKKDM4EL3MBTL1PPARAPPARD
SCHEMBL3573660 0.81 FAAH (0.40) DGAT1KCNH2FAAHMAPTMAOB
SCHEMBL3017912 0.81 PPARA (0.37) PPARAPPARGPPARDMCHR1DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778633-B1 INDOLES USEFUL IN THE TREATMENT OF INFLAMMATION BIOLIPOX AB (SE) 2008-12-03 EP disclosed
US-20080188473-A1 Indoles Useful in the Treatment of Inflammation BIOLIPOX AB (SE) 2008-08-07 US disclosed
EP-1778633-A1 INDOLES USEFUL IN THE TREATMENT OF INFLAMMATION Biolipox AB (SE) 2007-05-02 EP disclosed
WO-2005123674-A1 INDOLES USEFUL IN THE TREATMENT OF INFLAMMATION BIOLIPOX AB (SE) 2005-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188473-A1 Indoles Useful in the Treatment of Inflammation IDO1, PTGS1, PTGER1 GCK 2750/4885KDM4E 2149/4885L3MBTL1 3238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.